Annoyed by floating specks in your vision? You may soon be able to zap them away

November 13, 2017, American Academy of Ophthalmology

Millions of people who put up with seeing annoying specks drift through their field of vision may now have a safe, high-tech solution to their problem. A study of patients who had laser treatment to vaporize these flecks and spots known as floaters, showed a very low complication rate, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. Additionally, most patients reported a significant improvement in their vision.

Collecting long-term safety data is vital to determine the effectiveness of lasers for floaters. To that end, Inder Paul Singh, M.D., an ophthalmologist with the Eye Centers of Racine and Kenosha in Wisconsin, shared his results with 680 patients, who collectively underwent 1,272 laser procedures for large floaters. Dr. Singh saw these patients anywhere from one to four years to check for complications. Only 10, or 0.8 percent, experienced a complication. The most common complication was an increase in intraocular pressure, which was successfully treated with an antihypertensive eyedrop.

Eye floaters are a general term describing the specks, threads, cobweb-like images, or large clouds that can occasionally drift across the line of vision. Most floaters are bits of a protein called collagen. They're part of a gel-like substance in the back of the eye called the vitreous. As you age, the vitreous slowly shrinks and forms opacities of varying size and shape. What you see isn't the floater itself, but the shadow it casts onto the retina. Floaters can move as your eyes shift.

About one-quarter of people have some vitreous changes with floaters by age 60. By age 80, the number rises to about two-thirds. People are more likely to have them if they are nearsighted or have had cataract surgery. For some, floaters are a mere annoyance, but those with large floaters experience significant interference with their vision and daily functioning. A 2013 study found that about one-third of patients say floaters interfere with their daily activities.

Using a laser to break up larger floaters into smaller pieces so they are less visually disabling dates back to the 1980s. But most physicians counseled against using lasers to treat floaters due to reports that the laser couldn't properly visualize floaters, which could lead to inadvertent damage to the lens or retina, the light sensitive part of the eye that is essential to sight.

As technology has advanced, newer generation lasers have been designed to maximize visualization of the floaters in relation to the lens and retina. Energy is delivered more efficiently to break up or even vaporize floaters. These improvements have raised the possibility that treatment of could become a mainstream procedure in ophthalmology.

"The procedure and new technique is slowly growing in acceptance, and an increasing number of ophthalmologists are adopting it in Europe and the U.S.," said Dr. Singh. "We have also founded the International Ophthalmic Floater Society, which is open to ophthalmologists worldwide. It's aimed at studying the merits of this and other treatment options, sharing experiences and protocols, and raising awareness."

Explore further: Floaters are common as we age but may signal a more serious eye problem

Related Stories

Floaters are common as we age but may signal a more serious eye problem

February 6, 2017
Have you ever noticed the sudden appearance of a black dot in your field of vision that moves around when you move your eyes? It could also look like a cob web. You try blinking but it just won't go away. They can be quite ...

Laser treatment reduces eye floaters

July 20, 2017
Patients reported improvement in symptoms of eye floaters after treatment with a laser, according to a study published by JAMA Ophthalmology.

Drug approved for symptomatic vitreomacular adhesion

October 19, 2012
(HealthDay)—Jetrea (ocriplasmin) has been approved by the U.S. Food and Drug Administration to treat an eye condition called symptomatic vitreomacular adhesion (VMA).

Recommended for you

In effort to treat rare blinding disease, researchers turn stem cells into blood vessels

February 13, 2018
People who inherit a mutated version of the ATF6 gene are born with a malformed or missing fovea, the eye region responsible for sharp, detailed vision. From birth, their vision is severely limited, and there is no cure. ...

Antioxidant therapy prevents devastating vision loss when added to standard-of-care on rare birth defect

February 5, 2018
A new study led by vision researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and VA Western New York Healthcare System has demonstrated that the addition of widely available ...

Genetic basis for glaucoma uncovered

January 30, 2018
In two recent publications, Northwestern Medicine scientists and international collaborators discovered mutations that cause improper drainage and a buildup of ocular pressure leading to one form of congenital glaucoma, and ...

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.